Table 1 Diagnostic criteria used for metabolic syndrome by four metabolic syndrome definitions
Clinical measure | WHO (1998) | NCEP-ATP III (2004) | IDF (2005) | JIS (2009) |
|---|---|---|---|---|
Criteria needed for definition | insulin resistance + at least two further criteria needed | At least three of the following | Central obesity (WC) + at least two of the following | At least three of the following |
Central obesity | M: WHR > 0.90 F: WHR > 0.85 and/or BMI > 30 kg/m2 | M: WC ≥ 102 cm F: WC ≥ 88 cm | Increased WC (population specific) Europids: M: ≥ 94 cm F: ≥ 80 cm | Increased WC (population and country specific) Europids: M: ≥ 94 cm F: ≥ 80 cm |
Lipid metabolism | TG ≥ 150 mg/dl (1.7 mmol/l) and/ or M: HDL-C < 35 mg/dl (0.9 mmol/l) F: HDL-C < 39 mg/dl (1.0 mmol/l) | TG ≥ 150 mg/dl (1.7 mmol/l) | TG ≥ 150 mg/dl (1.7 mmol/l) | TG ≥ 150 mg/dl (1.7 mmol/l) |
M: HDL-C < 40 mg/dl (1.03 mmol/l) F: HDL-C < 50 mg/dl (1.3 mmol/l) | M: HDL-C < 40 mg/dl (1.03 mmol/l) F: HDL-C < 50 mg/dl (1.3 mmol/l) | M: HDL-C < 40 mg/dl (1.03 mmol/l) F: HDL-C < 50 mg/dl (1.3 mmol/l) | ||
Blood pressure (mmHg) | ≥140/90 or medication | ≥130/85 | ≥130/85 or medication | ≥130/85 or medication |
Glucose metabolism/insulin resistance | FPG ≥ 110 mg/dl (6.1 mmol/l) (indicating IFG) or T2DM diagnosis | FPG >100 mg/dl (5.6 mmol/l) or medication | FPG ≥ 100 mg/dl (5.6 mmol/l) or T2DM diagnosis | FPG ≥ 100 mg/dl (5.6 mmol/l) or medication |